Home › Funds › Longview Partners (Guernsey) LTD › WST

Longview Partners (Guernsey) LTD position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Longview Partners (Guernsey) LTD reported holding 927,466 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$343.9M, representing 5.59% of its reported portfolio and ranking #1 among its reported holdings. Longview Partners (Guernsey) LTD has disclosed WST holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)927.47K sh
Reported value held$343.87M
Portfolio Weight5.59%
First reportedQ3 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Longview Partners (Guernsey) LTD's WST position evolved

Longview Partners (Guernsey) LTD first disclosed a stake in WST in Q3 2025 at 352,139 shares (US$92.4M). The position peaked in Q2 2026 at 1,033,826 shares, worth US$371.1M. Across 5 filings, Longview Partners (Guernsey) LTD increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 927,466 shares valued at US$343.9M — a reduction of -106,360 shares quarter over quarter.. Notable position changes include a 221% increase in Q4 2025 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 352.14K $92.38M New
Q4 2025 1.13M $311.19M Add
Q1 2026 1.32M $329.69M Add
Q2 2026 1.03M $371.14M Reduce
Q3 2026 927.47K $343.87M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 27 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Longview Partners (Guernsey) LTD held WST?

Longview Partners (Guernsey) LTD has disclosed WST holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Longview Partners (Guernsey) LTD's current position in WST?

As of Q3 2026, Longview Partners (Guernsey) LTD holds 927.47K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $343.87M, representing 5.59% of its reported portfolio and ranking #1.

Has Longview Partners (Guernsey) LTD been buying or selling WST?

In the latest 13F filing (Q3 2026), Longview Partners (Guernsey) LTD reduced its position in WST. The position peaked in Q2 2026 at 1.03M shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.